Alexion Pharmaceuticals
0 sources
Financials
0000899866-21-000014Alexion Pharmaceuticals
Summary
Alexion Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (149 views/month).[2]
Key Facts
- Alexion Pharmaceuticals is in the country of United States[3].
- Alexion Pharmaceuticals's instance of is recorded as business[4].
- Alexion Pharmaceuticals's instance of is recorded as enterprise[5].
- Alexion Pharmaceuticals's instance of is recorded as public company[6].
- Alexion Pharmaceuticals's logo image is recorded as Alexion Logo.svg[7].
- Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[8].
- Alexion Pharmaceuticals's ISNI is recorded as 0000000404080730[9].
- Alexion Pharmaceuticals's child organization or unit is recorded as Alexion Pharma (Switzerland)[10].
- Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[11].
- Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
- +1992-01-01T00:00:00Z marks the founding of Alexion Pharmaceuticals[13].
- Alexion Pharmaceuticals's Freebase ID is recorded as /m/02_7bwl[14].
- Alexion Pharmaceuticals's location of formation is recorded as Boston[15].
- Alexion Pharmaceuticals's parent organization or unit is recorded as AstraZeneca[16].
- Alexion Pharmaceuticals's official website is recorded as https://alexion.com/[17].
- Alexion Pharmaceuticals's official website is recorded as http://www.alexion.com[18].
- Alexion Pharmaceuticals's ISIN is recorded as US0153511094[19].
- Alexion Pharmaceuticals's product or material produced is recorded as Soliris[20].
- Alexion Pharmaceuticals's product or material produced is recorded as Kanuma[21].
- Alexion Pharmaceuticals's product or material produced is recorded as ravulizumab[22].
- Alexion Pharmaceuticals's product or material produced is recorded as Strensiq[23].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3837'}[24].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+2656'}[25].
- Alexion Pharmaceuticals's employees is recorded as {'amount': '+3082'}[26].
- Alexion Pharmaceuticals's Legal Entity Identifier is recorded as M1YXUUZR0EIMU8T0EM75[27].
Body
Founding
+1992-01-01T00:00:00Z marks the founding of Alexion Pharmaceuticals[13]. Its location of formation is recorded as Boston[15].
Identity
Alexion Pharmaceuticals's short name is recorded as {'lang': 'en', 'text': 'Alexion'}[28].
Operations
Alexion Pharmaceuticals's headquarters location is recorded as Cheshire[8]. Its parent organization or unit is recorded as AstraZeneca[16]. Its child organization or unit is recorded as Alexion Pharma (Switzerland)[10].
Industry
Alexion Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
Ownership
Alexion Pharmaceuticals's stock exchange is recorded as Nasdaq[11]. Products include Soliris[20], Kanuma[21], ravulizumab[22], and Strensiq[23].
Why It Matters
Alexion Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (149 views/month).[2] It has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[29]